Development of Oral Controlled Release Tablet Formulations Based on Diltiazem–Carrageenan Complex

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmaceutical development and technology (Print)

• Publication date

  2004-01-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1081/PDT-120027428PMID 15202574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Particle size analysis

  2013cited by this paper
• Influence of complex solubility on formulations based on lambda carrageenan and basic drugs

  2008cited by this paper
• Particle Size Analysis

  2002cited by this paper
• Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.

  2001cited by this paper
• Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.

  2001cited by this paper
• Characterization of a diltiazem-lambda carrageenan complex.

  2000cited by this paper
• Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes

  2000cited by this paper
• Drug release from drug-polyanion complex tablets: poly(acrylamido-2-methyl-1-propanesulfonate sodium -co- methyl methacrylate).

  1999cited by this paper
• Optimization of sustained-release tablet formulations: a four-component mixture experiment.

  1999cited by this paper
• Matrix tablets of carrageenans. II. Release behavior and effect of added cations.

  1999cited by this paper
• The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets.

  1999cited by this paper
• On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix.

  1998cited by this paper
• A New Ternary Polymeric Matrix System for Controlled Drug Delivery of Highly Soluble Drugs: I. Diltiazem Hydrochloride

  1997cited by this paper
• Optimization of sustained-release tablet formulations: a four-component mixture experiment.

  1997cited by this paper
• Controlled-release tablet matrices from carrageenans: compression and dissolution studies.

  1997cited by this paper
• A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics.

  1996cited by this paper
• On the employment of λ-carrageenan in a matrix system. II: λ-carrageenan and hydroxypropylmethylcellulose mixtures

  1994cited by this paper
• On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum

  1993cited by this paper
• The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matrices

  1988cited by this paper
• A SIMPLE EQUATION FOR SOLUTE RELEASE PART 1. FICKIAN AND NONFICKIAN RELEASE FROM NONSWELLABLE DEVICES IN THE FORM OF SLABS, SPHERES, CYLINDERS OR DISKS

  1987cited by this paper
• A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs

  1987cited by this paper
• Handbook of Water Soluble Gums and Resins

  1980cited by this paper
• INTERACTION OF ANTIHISTAMINES WITH HYDROCOLLOIDS.

  1963cited by this paper

• Preparation and in Vitro/In Vivo Characterization of Sustained-Release Ciprofloxacin-Carrageenan Complex.

  2023cites this paper
• Natural Polymers Employed in Designing of Gastro Retentive Drug Delivery Systems

  2023cites this paper
• Natural polysaccharides: Chemical properties and application in pharmaceutical formulations

  2022cites this paper
• Seaweed-Based Biodegradable Biopolymers, Composite, and Blends with Applications

  2021cites this paper
• Natural polymers, gums and mucilages as efficacious green emissaries of essential therapeutics

  2020cites this paper
• Formation of Higher Structural Levels in λ-Carrageenan Induced by the Antimalarial Drug Chloroquine.

  2020cites this paper
• Sublingual tablets containing spray-dried carvedilol-loaded nanocapsules: development of an innovative nanomedicine

  2020cites this paper
• Structural changes and stress relaxation behavior of kappa-Carrageenan cold processed gels: effects of ultrasonication time and power.

  2019cites this paper
• Carrageenans and carrageenases: versatile polysaccharides and promising marine enzymes

  2018cites this paper
• pH-dependent release of antihypertensives from complexes with poly(carboxyalkyl methacrylamides)

  2017cites this paper
• Rational Design of Oral Modified-Release Drug Delivery Systems

  2017cites this paper
• Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications

  2016cites this paper
• Matrix tablets based on a carrageenan with the modified-release of sodium riboflavin 5′-phosphate

  2015cites this paper
• ESTIMATION OF THE DRUG-DRUG AND DRUG-POLYMER OPHTHALMIC COMPLEX AT STOICHIOMETRY BY TERNARY PHASE BEHAVIOUR Original Article

  2015cites this paper
• Pharmaceutical Natural Polymers: Structure and Chemistry

  2015cites this paper
• Study of drug-macromolecule interactions for the development of new oral controlled delivery systems

  2015cites this paper
• Microenvironmental pH Control and Mixed Polymer Approaches to Optimise Drug Delivery with Hydrophilic Matrix Tablets

  2014cites this paper
• Carrageenan and its applications in drug delivery.

  2014cites this paper
• Drug Release Kinetics and Front Movement in Matrix Tablets Containing Diltiazem or Metoprolol/λ-Carrageenan Complexes

  2014cites this paper
• Hydrophilic Matrix Tablets for Oral Controlled Release

  2014cites this paper
• Enhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulation.

  2013cites this paper
• Preparation and characterization of a novel once‐daily formulation of diltiazem using arabinogalactan as a channeling agent

  2012cites this paper
• Natural polymers, gums and mucilages as excipients in drug delivery.

  2012cites this paper
• Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.

  2011cites this paper
• Thermal characterization of diltiazem and λ-carrageenan binary systems

  2010cites this paper
• Investigation of Drug Polymer Interaction: Evaluation and Characterization of Diclofenac-Chitosan Co-precipitate

  2010cites this paper
• Chapter 20 – Rational Design of Oral Modified-Release Drug Delivery Systems

  2009cites this paper
• Novel Platforms for Oral Drug Delivery

  2009cites this paper
• Drug-organic electrolyte complexes as controlled release systems.

  2009cites this paper
• Drug–Organic Electrolyte Complexes as Controlled Release Systems

  2009cites this paper
• Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release.

  2008cites this paper
• Carrageenans in Solid Dosage Form Design

  2008cites this paper
• Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms

  2008cites this paper
• Polyelectrolyte–Drug Complexes of Lambda Carrageenan and Basic Drugs: Relevance of Particle Size and Moisture Content on Compaction and Drug Release Behavior

  2008cites this paper
• Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.

  2007cites this paper
• Effect of punch configuration on drug release from hydrophilic matrix tablets.

  2007cites this paper
• Noncross-Linked Copolymers of Dimethylaminoethyl Methacrylate and Methacrylic Acid as Oral Drug Carriers

  2006cites this paper
• Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization.

  2006cites this paper
• Thermoresponsive polymers as promising new materials for local radiotherapy.

  2005cites this paper